Page 4 - David Wald News Today

/PRNewswire/ -- Aclaimant, the leading, proactive RMIS platform, is proud to partner with The Liberty Company, one of the fastest growing privately held...

The partnership combines Aclaimants streamlined FNOL reporting with powerful analytics to support Libertys risk management services for insureds...

The home video release plans are set for this series.

Chimeric Therapeutics Ltd (ASX:CHM) is fairly priced at $0.71 per share based on recent developments, including its agreement with Case Western University...

Chimeric Therapeutics Ltd (ASX:CHM) CEO and managing director Jennifer Chow speaks with Andrew Scott from Proactive about entering into a sponsored research...

Chimeric Therapeutics Ltd (ASX:CHM) has entered into a sponsored research agreement (SRA) with Case Western Reserve University (CWRU) to further advance its...

/PRNewswire/ -- Aclaimant, the leading, proactive RMIS platform, is proud to announce an extended agreement with Riverstone Communities, a leading real estate...

Researchers at University Hospitals (UH) Seidman Cancer Center and a biotech start-up company have developed a streamlined way to manufacture CAR T-cells for immunotherapy treatment in just 24 hours – an improvement over the team's previous benchmark of eight days and commercial suppliers that typically take three weeks.

/PRNewswire/ -- Aclaimant, the leading, proactive RMIS platform, today announced a partnership with Safety National, a leading specialty insurance and...

Given, a music-themed boys' love anime series, was released back in 2019. Now, three years later, the anime is getting a dub release.